MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Heron Therapeutics Company Profile (NASDAQ:HRTX)

Consensus Ratings for Heron Therapeutics (NASDAQ:HRTX) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.44 (167.94% upside)

Analysts' Ratings History for Heron Therapeutics (NASDAQ:HRTX)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Brean CapitalReiterated RatingBuy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Noble FinancialReiterated RatingBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingBuy$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016Lake Street CapitalReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015JMP SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015Bank of AmericaBoost Price TargetBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha